184 results on '"Olivenstein, Ronald"'
Search Results
2. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
3. The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study
4. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
5. Derangement of cell cycle markers in peripheral blood mononuclear cells of asthmatic patients as a reliable biomarker for asthma control
6. Author Correction: Derangement of cell cycle markers in peripheral blood mononuclear cells of asthmatic patients as a reliable biomarker for asthma control
7. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study
8. Effect of bronchial thermoplasty on structural changes and inflammatory mediators in the airways of subjects with severe asthma
9. Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
10. Neutrophils from severe asthmatic patients induce epithelial to mesenchymal transition in healthy bronchial epithelial cells
11. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
12. IL ‐5 receptor expression in lung fibroblasts: Potential role in airway remodeling in asthma
13. Targeting KDM4B attenuates IL-13-mediated fibrosis in bronchial fibroblasts of severe asthmatics
14. Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma
15. The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study
16. Montelukast added to fluticasone propionate does not alter inflammation or outcomes
17. Airway smooth muscle remodeling is a dynamic process in severe long-standing asthma
18. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma
19. Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction
20. Prevalence of obstructive sleep apnea–hypopnea in severe versus moderate asthma
21. Differences in Airway Cytokine Profile in Severe Asthma Compared to Moderate Asthma
22. Action of 1,25(OH)2D3 on Human Asthmatic Bronchial Fibroblasts: Implications for Airway Remodeling in Asthma
23. Asthma control during the year after bronchial thermoplasty
24. Wnt Signaling Is Deranged in Asthmatic Bronchial Epithelium and Fibroblasts
25. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
26. Clinical features and airway inflammation in mild asthma versus asymptomatic airway hyperresponsiveness
27. Genetic and histologic evidence for autophagy in asthma pathogenesis
28. IL-13 Augments Histone Demethylase JMJD2B/KDM4B Expression Levels, Activity, and Nuclear Translocation in Airway Fibroblasts in Asthma
29. Peculiar Phenotypic and Cytotoxic Features of Pulmonary Mucosal CD8 T Cells in People Living with HIV Receiving Long-Term Antiretroviral Therapy
30. Enhanced mitophagy in bronchial fibroblasts from severe asthmatic patients
31. Blood and Salivary Amphiregulin Levels as Biomarkers for Asthma
32. Asthma and fixed airflow obstruction: Long‐term trajectories suggest distinct endotypes
33. Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena
34. IL-17 Induced Autophagy Regulates Mitochondrial Dysfunction and Fibrosis in Severe Asthmatic Bronchial Fibroblasts
35. Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial
36. Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial
37. Increased glucocorticoid receptor–β expression, but not decreased histone deacetylase 2, in severe asthma
38. Action of 1,25(OH)2D3 on Human Asthmatic Bronchial Fibroblasts: Implications for Airway Remodeling in Asthma
39. 5-Oxo-6,8,11,14-eicosatetraenoic acid induces the infiltration of granulocytes into human skin
40. Increased Expression of the Chemoattractant Cytokines Eotaxin, Monocyte Chemotactic Protein-4, and Interleukin-16 in Induced Sputum in Asthmatic Patients*
41. CD8 Depletion–induced Late Airway Response Is Characterized by Eosinophilia, Increased Eotaxin, and Decreased IFN-γ Expression in Rats
42. IL-9 and its receptor in allergic and nonallergic lung disease: Increased expression in asthma
43. Automatic Control of Pressure Support Mechanical Ventilation Using Fuzzy Logic
44. Ten-year follow-up of subjects who received bronchial thermoplasty (BT) in 3 randomized controlled studies (BT10+)
45. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study
46. Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial
47. Gene expression of the GATA-3 transcription factor is increased in atopic asthma
48. Depletion of CD8+ T cells enhances pulmonary inflammation but not airway responsiveness after antigen challenge in rats
49. Use of Montelukast in tapering inhaled corticosteroid therapy: an open-label, 48-week trial
50. Effect of Dexamethasone on Airway Inflammation and Responsiveness after Antigen Challenge of the Rat
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.